electroCore to Present at the Canaccord Genuity Growth Conference

Rhea-AI Summary

On August 2, 2021, electroCore announced its participation in the Canaccord Genuity Growth Conference, set for August 10-12, 2021. The company's management will present on August 12 at 8:30 am EDT. This conference offers a platform for virtual one-on-one meetings with investors. Following the event, a recording of the presentation will be accessible on the investor section of the company's website. electroCore specializes in bioelectronic medicine, focusing on non-invasive vagus nerve stimulation therapies for neurological conditions, including migraine and cluster headaches.

ROCKAWAY, NJ, Aug. 02, 2021 (GLOBE NEWSWIRE) -- electroCore, Inc. (the “Company”), (NASDAQ: ECOR), a commercial-stage bioelectronic medicine company, today announced that its management team will give a corporate presentation and be available for virtual one-on-one meetings at the Canaccord Genuity Growth Conference. The conference is taking place virtually from August 10 - 12, 2021. Details for the presentation are as follows:

Canaccord Genuity Growth Conference:
Date: Thursday, August 12, 2021
Time: 8:30 am EDT
Investors can register for the conference HERE.

Following the conference a webcast replay of the presentation will be available on the Investor section of the company’s website, www.electrocore.com.

About electroCore, Inc.
electroCore, Inc. is a commercial stage bioelectronic medicine company dedicated to improving patient outcomes through its non-invasive vagus nerve stimulation therapy platform, initially focused on the treatment of multiple conditions in neurology. The company's current indications are the preventive treatment of cluster headache and migraine and the acute treatment of migraine and episodic cluster headache.

For more information, visit www.electrocore.com.

FAQ

When will electroCore present at the Canaccord Genuity Growth Conference?

electroCore will present on August 12, 2021, at 8:30 am EDT.

How can I access the electroCore presentation after the conference?

A webcast replay of the presentation will be available on the investor section of electroCore's website.

What is the focus of electroCore's bioelectronic medicine?

electroCore focuses on non-invasive vagus nerve stimulation therapy for treating neurological conditions such as migraines and cluster headaches.

What are the dates for the Canaccord Genuity Growth Conference?

The conference will take place virtually from August 10 to August 12, 2021.

What conditions does electroCore's therapy target?

electroCore's therapy targets the preventive and acute treatment of cluster headaches and migraines.